Related Experiment Video
Updated: Mar 22, 2026

Testing Sensory and Multisensory Function in Children with Autism Spectrum Disorder
Published on: April 22, 2015
Sulforaphane Treatment of Young Men with Autism Spectrum Disorder
Kanwaljit Singh, Andrew W Zimmerman1
1UMass Memorial Medical Center, University of Massachusetts Medical School, 55 Lake Ave, Worcester, MA, 01655, USA. Andrew.Zimmerman@umassmemorial.org.
Insights
Fever may improve behaviors in children with Autism Spectrum Disorder (ASD) by altering cellular stress responses. Sulforaphane, a broccoli sprout compound, mimics this "fever effect" and shows promise in a clinical trial for young adults with ASD.
Area of Science:
- Neurodevelopmental Disorders
- Biochemistry
- Clinical Trials
Background:
- Autism Spectrum Disorder (ASD) is a neurodevelopmental condition affecting at least 1% of children, characterized by behavioral and communication differences.
- Febrile illness has been observed to improve behaviors in a subset of children with ASD, potentially linked to heat shock proteins (HSP) and cellular stress responses.
- Sulforaphane, a phytochemical from cruciferous vegetables like broccoli sprouts, exhibits metabolic effects similar to fever.
Purpose of the Study:
- To discuss the
- fever effect
- observed in Autism Spectrum Disorder.
- To explore the intracellular effects of sulforaphane and its potential role in modulating cellular stress responses relevant to ASD.
- To present findings from a recent clinical trial investigating sulforaphane in young adults with autism.
Main Methods:
- Review of existing literature on the "fever effect" in ASD and the metabolic actions of sulforaphane.
- Analysis of intracellular effects of sulforaphane, including its impact on heat shock proteins and cellular stress pathways.
- Presentation and discussion of results from a clinical trial involving sulforaphane administration in young adults with ASD.
Main Results:
- Observational studies suggest a correlation between febrile illness and behavioral improvements in some individuals with ASD.
- Sulforaphane's metabolic properties resemble those of fever, indicating a potential therapeutic mechanism.
- Preliminary clinical trial data on sulforaphane in young adults with autism are discussed, suggesting potential benefits.
Conclusions:
- The
- fever effect
- in ASD warrants further investigation as a potential therapeutic avenue.
- Sulforaphane presents a promising phytochemical intervention due to its ability to mimic fever-induced cellular changes.
- Further research, including clinical trials, is crucial to validate the efficacy of sulforaphane for Autism Spectrum Disorder.
Abstract:
Autism Spectrum Disorder (ASD) comprises a heterogeneous group of neurodevelopmental disorders that begin in early childhood. They are characterized by differences in behavior and delays in communication and affect at least 1% of children. Observational studies have now confirmed that behaviors of a substantial percentage of children with autism tend to improve with the onset of febrile illness, which might be the downstream effects of altered metabolic pathways involving increased expression of heat shock proteins (HSP) and cellular stress responses. Sulforaphane, a phytochemical derived from a number of cruciferous vegetables, most notably broccoli sprouts, has metabolic effects that in some ways resemble that of fever. This review paper discusses this "fever effect" and the intracellular effects of sulforaphane as well as the results of our recent clinical trial of sulforaphane in young adults with autism. The accompanying review by Liu et al. describes the cellular actions of sulforaphane and potential biomarkers in the study of ASD.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

